Genenta Science S.p.A GNTA Stock
Genenta Science S.p.A Price Chart
Genenta Science S.p.A GNTA Financial and Trading Overview
| Genenta Science S.p.A stock price | 4.2 USD |
| Previous Close | 5.91 USD |
| Open | 5.9 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 5.74 - 6 USD |
| 52 Week Range | 3.9 - 9.33 USD |
| Volume | 984 USD |
| Avg. Volume | 2.44K USD |
| Market Cap | 104.57M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.75 USD |
GNTA Valuation Measures
| Enterprise Value | 81.42M USD |
| Trailing P/E | N/A |
| Forward P/E | -10.070175 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.358689 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.376 |
Trading Information
Genenta Science S.p.A Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -26.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.33 USD |
| 52 Week Low | 3.9 USD |
| 50-Day Moving Average | 5.98 USD |
| 200-Day Moving Average | 5.66 USD |
GNTA Share Statistics
| Avg. Volume (3 month) | 2.44K USD |
| Avg. Daily Volume (10-Days) | 3.17K USD |
| Shares Outstanding | 18.22M |
| Float | 10.81M |
| Short Ratio | 0.63 |
| % Held by Insiders | 39.46% |
| % Held by Institutions | 2.64% |
| Shares Short | 1.29K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.79% |
| Return on Equity (ttm) | -24.22% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11037852 USD |
| Net Income Avi to Common (ttm) | -8477763 USD |
| Diluted EPS (ttm) | -0.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.79M USD |
| Total Cash Per Share (mrq) | 1.64 USD |
| Total Debt (mrq) | 39.08K USD |
| Total Debt/Equity (mrq) | 0.13 USD |
| Current Ratio (mrq) | 14.528 |
| Book Value Per Share (mrq) | 1.709 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7418236 USD |
| Levered Free Cash Flow (ttm) | -5571566 USD |
Profile of Genenta Science S.p.A
| Country | United States |
| State | MI |
| City | Milan |
| Address | Via Olgettina No. 58 |
| ZIP | 20132 |
| Phone | 39 02 26 43 46 81 |
| Website | https://www.genenta.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Q&A For Genenta Science S.p.A Stock
What is a current GNTA stock price?
Genenta Science S.p.A GNTA stock price today per share is 4.2 USD.
How to purchase Genenta Science S.p.A stock?
You can buy GNTA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genenta Science S.p.A?
The stock symbol or ticker of Genenta Science S.p.A is GNTA.
Which industry does the Genenta Science S.p.A company belong to?
The Genenta Science S.p.A industry is Biotechnology.
How many shares does Genenta Science S.p.A have in circulation?
The max supply of Genenta Science S.p.A shares is 18.29M.
What is Genenta Science S.p.A Price to Earnings Ratio (PE Ratio)?
Genenta Science S.p.A PE Ratio is now.
What was Genenta Science S.p.A earnings per share over the trailing 12 months (TTM)?
Genenta Science S.p.A EPS is -0.56 USD over the trailing 12 months.
Which sector does the Genenta Science S.p.A company belong to?
The Genenta Science S.p.A sector is Healthcare.
Genenta Science S.p.A GNTA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}